Literature DB >> 8834903

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

J Versalovic1, D Shortridge, K Kibler, M V Griffy, J Beyer, R K Flamm, S K Tanaka, D Y Graham, M F Go.   

Abstract

Twelve clarithromycin-resistant Helicobacter pylori isolates (100% of resistant isolates examined) from seven different patients each contained an A-->G transition mutation within a conserved loop of 23S rRNA. A-->G transition mutations at positions cognate with Escherichia coli 23S rRNA positions 2058 and 2059 were identified. Clarithromycin-susceptible H. pylori isolates from 14 different patients displayed no polymorphisms in a conserved loop within domain V of 23S rRNA. The study is the first to report mutations in H. pylori associated with resistance to an antimicrobial agent used in established peptic ulcer treatment regimens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834903      PMCID: PMC163139     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Point mutations in the 23 S rRNA genes of four lincomycin resistant Nicotiana plumbaginifolia mutants could provide new selectable markers for chloroplast transformation.

Authors:  A Cseplö; T Etzold; J Schell; P H Schreier
Journal:  Mol Gen Genet       Date:  1988-10

2.  A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin.

Authors:  B Vester; R A Garrett
Journal:  Biochimie       Date:  1987-08       Impact factor: 4.079

3.  Functional consequences of binding macrolides to ribosomes.

Authors:  J R Menninger
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

4.  Healing gastric MALT lymphomas by eradicating H pylori?

Authors:  M Stolte; S Eidt
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

5.  Identification of two erythromycin resistance mutations in the mitochondrial gene coding for the large ribosomal RNA in yeast.

Authors:  F Sor; H Fukuhara
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

6.  Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.

Authors:  D Y Graham; G M Lew; P D Klein; D G Evans; D J Evans; Z A Saeed; H M Malaty
Journal:  Ann Intern Med       Date:  1992-05-01       Impact factor: 25.391

7.  Eradication of Helicobacter pylori with clarithromycin and omeprazole.

Authors:  R P Logan; P A Gummett; H D Schaufelberger; R R Greaves; G M Mendelson; M M Walker; P H Thomas; J H Baron; J J Misiewicz
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

8.  Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

Authors:  D J Hardy; C W Hanson; D M Hensey; J M Beyer; P B Fernandes
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

9.  Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli.

Authors:  M Ettayebi; S M Prasad; E A Morgan
Journal:  J Bacteriol       Date:  1985-05       Impact factor: 3.490

10.  Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA.

Authors:  D Moazed; H F Noller
Journal:  Biochimie       Date:  1987-08       Impact factor: 4.079

View more
  151 in total

1.  Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori.

Authors:  J R Gibson; N A Saunders; B Burke; R J Owen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.

Authors:  M Matsumura; Y Hikiba; K Ogura; G Togo; I Tsukuda; K Ushikawa; Y Shiratori; M Omata
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.

Authors:  F Depardieu; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 4.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.

Authors:  T Alarcón; D Domingo; N Prieto; M López-Brea
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.

Authors:  B Björkholm; M Sjölund; P G Falk; O G Berg; L Engstrand; D I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

7.  Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization.

Authors:  H Rüssmann; K Adler; R Haas; B Gebert; S Koletzko; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

8.  Clarithromycin resistance in Helicobacter pylori and its clinical relevance.

Authors:  Hua-Xiang Xia; Xue-Gong Fan; Nicholas J Talley
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

9.  PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin.

Authors:  Armelle Ménard; Adriana Santos; Francis Mégraud; Mónica Oleastro
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

10.  Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects.

Authors:  Paolo Scarpellini; Paola Carrera; Annalisa Cavallero; Massimo Cernuschi; Gianni Mezzi; Pier Alberto Testoni; Anna Zingale; Adriano Lazzarin
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.